xaira
PrivateLast Round
Series A
4/23/2024
Last Round Size
$1B
Est. Valuation
$2.7B
Total Funding Raised
$1B
Company Overview
Xaira Therapeutics is a biotechnology company focused on leveraging advanced artificial intelligence tools to enhance drug discovery and development through comprehensive product development and data generation.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
xaira Comps
Related companies by embedding similarity.
xaira Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | 4/23/2024 |
xaira Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about xaira's valuation, stock price, and market status.
